Condition
Hepatitis B Vaccination
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06876467RecruitingPrimary
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus
NCT05787899Completed
Hypothermia's Effect on Hepatitis B Vaccination
NCT02959775Phase 4CompletedPrimary
Immunogenicity of Hepatitis B Vaccination Among Drug Users
NCT04162223Early Phase 1CompletedPrimary
Hepatitis B Vaccine in Seniors
NCT02166671Not ApplicableTerminatedPrimary
Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years
Showing all 5 trials